Event Type
Disclosure
Mandatory
Variant
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Metagenomi Therapeutics, Inc. (the “Company”) filed a certificate of amendment to its
(including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amen
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Certificate of Amendment to Amended and Restated Certificate of Incorporation of Met